Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients

This study has been terminated.
Sponsor:
Collaborators:
Carlos III Health Institute
Rovi Pharmaceuticals Laboratories
Information provided by:
Spanish National Health System
ClinicalTrials.gov Identifier:
NCT00399425
First received: November 13, 2006
Last updated: NA
Last verified: November 2006
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: April 2004
  Estimated Primary Completion Date: No date given